STANSBERRY ASSET MANAGEMENT, LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
STANSBERRY ASSET MANAGEMENT, LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$369,169
+21.5%
77,232
+8.0%
0.06%
+16.1%
Q2 2023$303,854
-19.2%
71,495
+0.9%
0.06%
-23.3%
Q1 2023$376,251
-14.4%
70,857
+1.2%
0.07%
-19.8%
Q4 2022$439,625
-38.4%
70,004
+3.5%
0.09%
-40.9%
Q3 2022$714,000
+89.9%
67,662
-2.4%
0.15%
+92.5%
Q2 2022$376,000
-55.9%
69,338
-25.3%
0.08%
-42.0%
Q1 2022$852,000
-16.2%
92,789
+37.7%
0.14%
-15.3%
Q4 2021$1,017,000
+56.0%
67,371
+146.6%
0.16%
+24.4%
Q3 2021$652,00027,3240.13%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,266,04015.18%
Elmwood Wealth Management, Inc. 2,364,415$11,301,9045.45%
PFM Health Sciences, LP 6,724,715$32,144,1381.51%
SILVERARC CAPITAL MANAGEMENT, LLC 892,786$4,267,5171.29%
Avidity Partners Management LP 6,050,212$28,920,0131.16%
Paradigm Biocapital Advisors LP 2,944,513$14,074,7720.96%
Kynam Capital Management, LP 1,068,527$5,107,5590.84%
Green Alpha Advisors, LLC 110,524$528,3050.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,500,000$16,730,0000.37%
Bruce & Co., Inc. 200,000$956,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders